Several studies on Treg in other autoimmune diseases, such as type 1 diabetes and rheumatoid arthritis, suggest a loss of Foxp3 expression and the generation of pathogenic Th17 cells (48), in association with Foxp3 instability in Tregs in these diseases. Here, FOXP3 is linked to type 1 diabetes mellitus.